CH579055A5 - - Google Patents

Info

Publication number
CH579055A5
CH579055A5 CH1208172A CH1208172A CH579055A5 CH 579055 A5 CH579055 A5 CH 579055A5 CH 1208172 A CH1208172 A CH 1208172A CH 1208172 A CH1208172 A CH 1208172A CH 579055 A5 CH579055 A5 CH 579055A5
Authority
CH
Switzerland
Application number
CH1208172A
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CH579055A5 publication Critical patent/CH579055A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/46—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1208172A 1971-08-16 1972-08-15 CH579055A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17232171A 1971-08-16 1971-08-16
US00268380A US3821244A (en) 1971-08-16 1972-07-03 2-amino-4-phenyl-2-imidazolines

Publications (1)

Publication Number Publication Date
CH579055A5 true CH579055A5 (fr) 1976-08-31

Family

ID=26867960

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1357975A CH591451A5 (fr) 1971-08-16 1972-08-15
CH1208172A CH579055A5 (fr) 1971-08-16 1972-08-15

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1357975A CH591451A5 (fr) 1971-08-16 1972-08-15

Country Status (16)

Country Link
US (1) US3821244A (fr)
JP (1) JPS5719106B2 (fr)
BE (1) BE787617A (fr)
CA (1) CA1018174A (fr)
CH (2) CH591451A5 (fr)
DE (1) DE2240256A1 (fr)
DK (1) DK139098B (fr)
FR (1) FR2150766B1 (fr)
GB (1) GB1347930A (fr)
HU (1) HU165660B (fr)
IE (1) IE36865B1 (fr)
IL (1) IL40123A (fr)
NL (1) NL7211173A (fr)
PH (2) PH11940A (fr)
SE (1) SE406763B (fr)
YU (1) YU35355B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914249A (en) * 1973-10-30 1975-10-21 Mead Johnson & Co 4-(3,4-Dichlorophenyl)-2-(methylamino)-2-imadazoline
US3953348A (en) * 1973-12-13 1976-04-27 Standard Oil Company Oil-soluble reaction products of intermediate (a) from a high molecular weight olefin polymer, acetonitrile, and chlorine with (b) a piperazine, and lubricant compositions containing the same
HU179019B (en) * 1978-11-01 1982-08-28 Gyogyszekutato Intezet Process for preparing 4-//3,4-dialkoxy-phenyl/-alkyl/- 2imidazolidinone derivatives
JPS5877051U (ja) * 1981-11-16 1983-05-24 富士通株式会社 Ｉｃアダプタ
EP0200947B1 (fr) * 1985-04-26 1990-09-12 F. Hoffmann-La Roche Ag Sels d'imidazolium substitué en position 1,3
HUP9802260A3 (en) * 1995-09-07 1999-10-28 Novartis Ag Substituted phosphinic compounds preparation and their use as pharmaceuticals and pharmaceutical compositions
HUP0400405A3 (en) * 2004-02-10 2009-03-30 Sanofi Synthelabo Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates

Also Published As

Publication number Publication date
SE406763B (sv) 1979-02-26
YU35355B (en) 1980-12-31
FR2150766A1 (fr) 1973-04-13
HU165660B (fr) 1974-10-28
NL7211173A (fr) 1973-02-20
DE2240256A1 (de) 1973-02-22
JPS4829770A (fr) 1973-04-19
FR2150766B1 (fr) 1976-05-21
GB1347930A (en) 1974-02-27
JPS5719106B2 (fr) 1982-04-20
IE36865B1 (en) 1977-03-16
PH11915A (en) 1978-09-08
YU207472A (en) 1980-06-30
US3821244A (en) 1974-06-28
DK139098C (fr) 1979-05-28
PH11940A (en) 1978-09-15
CH591451A5 (fr) 1977-09-15
DK139098B (da) 1978-12-18
IE36865L (en) 1973-02-16
BE787617A (fr) 1973-02-16
IL40123A (en) 1975-05-22
IL40123A0 (en) 1972-10-29
CA1018174A (en) 1977-09-27

Similar Documents

Publication Publication Date Title
DK139098C (fr)
AU460471B2 (fr)
AU2658571A (fr)
AU3005371A (fr)
AU2952271A (fr)
AU2941471A (fr)
AU2564071A (fr)
AU2894671A (fr)
AU2684071A (fr)
AU451756B2 (fr)
AU2907471A (fr)
AU2836771A (fr)
AU2940971A (fr)
AU2755871A (fr)
AU2654071A (fr)
AU2588771A (fr)
AU2938071A (fr)
AU2577671A (fr)
AU2930871A (fr)
AU2927871A (fr)
AU2885171A (fr)
AU2880771A (fr)
AU2963771A (fr)
AU2684171A (fr)
AU3025871A (fr)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased